Developer of healthcare products for mobile devices, Leman Micro Devices (LMD), has issues a note of warning about the need for medical accuracy, whilst also welcoming other companies into the market.
Smart phones
Mark-Eric Jones, founder & CEO of LMD, said: “We are tremendously excited that prominent companies are actively promoting the ubiquitous smartphone as a sophisticated and potentially life-saving medical tool. The recent announcement by Taiwanese company MediaTek shows the degree of confidence that industry has in this approach.”
The company’s medically-accurate sensor, that can be used within a smartphone to measure blood pressure and other vital signs, was launched at the start of 2017 at the Mobile World Congress in Barcelona.
LMD’s V-Sensor and app measures blood pressure by having users press their index finger onto the sensor. The app uses gamification and ensures that the correct pressure is applied for the correct length of time so users obtain a medically-accurate blood pressure reading.
The company is awaiting clinical trials for its V-Sensor and app early in 2018 before submission to the FDA for certification of medical accuracy.
“Medical accuracy is the last barrier that industry must overcome before we see the smartphone become accepted as a device that is trusted by users as well as doctors and other professionals worldwide to provide precise, repeatable analysis of the user’s state of health.” Jones added.